FG
BSX icon

Foster Group’s Boston Scientific BSX Stock Holding History

Foster Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,308
Closed -$220K – 290
2025
Q4 		$220K Sell
2,308
-499
-18% -$48.9K 0.01% 270
2025
Q3 		$274K Sell
2,807
-81
-3% -$8.39K 0.01% 216
2025
Q2 		$310K Buy
2,888
+46
+2% +$4.65K 0.01% 190
2025
Q1 		$287K Buy
+2,842
New +$286K 0.01% 164

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Foster Group's BSX Position: Q1 2026 in Review

Foster Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,308 shares — an estimated $220K sold.

Foster Group first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $310K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Foster Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Foster Group sold 2,308 Boston Scientific shares in Q1 2026, an estimated $220K.
  • Foster Group first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
  • Foster Group's Boston Scientific position peaked at $310K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Foster Group's 13F filing for Q1 2026, filed 13 Apr 2026.